Today, you will hear information about testing your male partner with a relatively new test called SpermQT. This week, the Fertility Docs, Dr. Carrie Bedient from the Fertility Center of Las Vegas, Dr. Susan Hudson from Texas Fertility Center, and Dr. Abby Eblen from Nashville Fertility Center welcome a groundbreaking guest: Dr. Kristin Brogaard, Chief Scientific Officer and Founder of Path Fertility. Kristin joins the Docs to discuss SpermQT, one of the first major innovations in male fertility testing in years. SpermQT goes beyond a traditional semen analysis to assess sperm DNA and determine whether sperm is capable of fertilizing an egg. If the SpermQT test is abnormal, it strongly suggests that natural conception or IUI will likely fail, making IVF the recommended next step.

Kristin shares how Path Fertility is conducting multiple studies to evaluate pregnancy outcomes when the SpermQT test is applied to men whose partners conceive naturally or through IUI and aims to track pregnancy through delivery. Future analysis in the IVF lab will evaluate fertilization and embryo development in men with normal versus abnormal testing. SpermQT is helping to redefine how we understand male fertility, challenging the outdated assumption that a normal semen analysis equals fertility. If you order the test the DISCOUNT CODE is FDU. ReceptivaDx sponsored this podcast.